Illustrative image – not actual.UK-based pharmaceutical company, Astra Zeneca, is planning to invest ₤25 million for conducting research on development of a tuberculosis vaccine at Bangalore in Karnataka.
Related news:
AstraZeneca
to invest $5 million per year in India till 2005
